南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停

新型NPRL3基因突变在局灶性癫痫家系中的功能研究

Functional characterization of novel NPRL3 mutations identified in three families with focal epilepsy

Du Shiyue, Zeng Sheng, Song Li, Ma Hongying, Chen Rui, Luo Junyu, Wang Xu, Ma Tingbin, Xu Xuan, Sun Hao, Yi Ping, Guo Jifeng, Huang Yaling, Liu Mugen, Wang Tao, Liao Wei-Ping, Zhang Luoying, Liu Jing

Journal:Science China-Life Sciences

IF:9.1

DOI:10.1007/s11427-022-2313-1

PMID:37071290

Published:2023-04-12

research field:神经科学分子生物学遗传学

Abstract

Focal epilepsy accounts for 60% of all forms of epilepsy, but the pathogenic mechanism is not well understood. In this study, three novel mutations in NPRL3 ( nitrogen permease regulator-like 3 ), c.937_945del, c.1514dupC and 6,706-bp genomic DNA (gDNA) deletion, were identified in three families with focal epilepsy by linkage analysis, whole exome sequencing (WES) and Sanger sequencing. NPRL3 protein is a component of the GATOR1 complex, a major inhibitor of mTOR signaling. These mutations led to truncation of the NPRL3 protein and hampered the binding between NPRL3 and DEPDC5, which is another component of the GATOR1 complex. Consequently, the mutant proteins enhanced mTOR signaling in cultured cells, possibly due to impaired inhibition of mTORC1 by GATOR1. Knockdown of nprl3 in Drosophila resulted in epilepsy-like behavior and abnormal synaptic development. Taken together, these findings expand the genotypic spectrum of NPRL3-associated focal epilepsy and provide further insight into how NPRL3 mutations lead to epilepsy.

本文使用的Yeasen产品

购物车
客服
转染试用